Vertiv Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Vertiv Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||
net income | 178,100,000 | -5,900,000 | 232,600,000 | 94,100,000 | 83,200,000 | 50,300,000 | 26,600,000 | 21,200,000 | 20,300,000 | 8,500,000 | 22,000,000 | 56,200,000 | 9,700,000 | 31,700,000 | 74,900,000 | -15,800,000 | 26,200,000 | -268,900,000 | -3,176,317 | 2,123,979 | 2,747,555 | 2,694,579 | 2,348,869 | 2,296,093 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||
depreciation | 20,100,000 | 19,800,000 | 19,700,000 | 18,900,000 | 18,000,000 | 17,700,000 | 18,700,000 | 17,800,000 | 17,600,000 | 17,900,000 | 17,500,000 | 16,400,000 | 18,300,000 | 16,900,000 | 17,400,000 | 14,400,000 | 14,300,000 | 14,200,000 | ||||||
amortization | 48,300,000 | 48,900,000 | 49,200,000 | 49,300,000 | 49,300,000 | 48,900,000 | 51,800,000 | 57,900,000 | 59,400,000 | 61,300,000 | 52,400,000 | 35,000,000 | 35,200,000 | 35,300,000 | 35,000,000 | 35,800,000 | 35,700,000 | 36,300,000 | ||||||
deferred income taxes | 4,800,000 | -7,600,000 | -130,900,000 | -2,300,000 | -1,800,000 | 3,400,000 | 13,400,000 | -12,800,000 | -4,600,000 | -4,600,000 | -47,500,000 | 0 | -14,800,000 | -7,500,000 | 6,300,000 | -1,800,000 | -2,300,000 | -3,600,000 | ||||||
amortization of debt discount and issuance costs | 2,000,000 | 2,100,000 | 1,600,000 | 1,600,000 | 2,000,000 | 2,700,000 | 100,000 | 2,600,000 | 2,500,000 | 2,300,000 | 1,700,000 | 1,300,000 | 1,500,000 | 1,800,000 | 1,500,000 | 1,400,000 | 1,700,000 | 5,900,000 | ||||||
change in fair value of warrant liabilities | 25,400,000 | 176,600,000 | 54,500,000 | 61,600,000 | 46,000,000 | -4,200,000 | 33,100,000 | 9,800,000 | -38,900,000 | -94,900,000 | 9,600,000 | -32,500,000 | 71,200,000 | 13,600,000 | ||||||||||
changes in operating working capital | 96,100,000 | -99,700,000 | 84,500,000 | 17,700,000 | 51,400,000 | -86,900,000 | -1,200,000 | -70,200,000 | -261,700,000 | -116,100,000 | 27,200,000 | -33,900,000 | -81,500,000 | -44,600,000 | 41,300,000 | 66,500,000 | -34,200,000 | -134,400,000 | ||||||
stock-based compensation | 8,500,000 | 9,200,000 | 6,200,000 | 6,500,000 | 6,800,000 | 5,500,000 | 4,600,000 | 6,300,000 | ||||||||||||||||
other | -4,900,000 | -5,900,000 | 38,800,000 | 1,300,000 | -1,300,000 | 4,600,000 | 37,300,000 | -28,200,000 | -7,500,000 | -4,500,000 | 2,700,000 | -4,200,000 | 13,700,000 | 5,700,000 | -15,500,000 | 26,200,000 | 19,300,000 | -18,200,000 | ||||||
net cash from operating activities | 378,400,000 | 137,500,000 | 356,200,000 | 248,700,000 | 253,600,000 | 42,000,000 | 180,700,000 | 4,400,000 | -205,700,000 | -132,200,000 | 36,500,000 | 54,400,000 | 59,300,000 | 60,700,000 | 194,500,000 | 136,100,000 | 73,000,000 | -194,700,000 | 3,478,760 | -587,067 | ||||
cash flows from investing activities: | ||||||||||||||||||||||||
capital expenditures | -34,100,000 | -35,800,000 | -47,800,000 | -26,500,000 | -25,800,000 | -27,800,000 | -38,300,000 | -23,500,000 | -23,100,000 | -15,100,000 | -30,100,000 | -12,900,000 | -13,600,000 | -16,800,000 | -23,100,000 | -8,100,000 | -6,500,000 | -6,700,000 | ||||||
free cash flows | 344,300,000 | 101,700,000 | 308,400,000 | 222,200,000 | 227,800,000 | 14,200,000 | 142,400,000 | -19,100,000 | -228,800,000 | -147,300,000 | 6,400,000 | 41,500,000 | 45,700,000 | 43,900,000 | 171,400,000 | 128,000,000 | 66,500,000 | -201,400,000 | ||||||
investments in capitalized software | -10,900,000 | -700,000 | -3,300,000 | -900,000 | -500,000 | -2,000,000 | -3,000,000 | -1,300,000 | -3,600,000 | -3,100,000 | -1,700,000 | -4,100,000 | -4,300,000 | -1,100,000 | -3,400,000 | 1,300,000 | -4,400,000 | -1,800,000 | ||||||
proceeds from disposition of property, plant and equipment | 0 | 0 | 0 | 12,400,000 | 3,700,000 | |||||||||||||||||||
net cash from investing activities | -45,000,000 | -36,500,000 | -68,000,000 | -27,400,000 | -26,300,000 | -17,400,000 | -37,400,000 | -24,800,000 | -31,700,000 | -18,200,000 | -1,170,100,000 | -10,900,000 | -17,900,000 | -17,900,000 | -19,500,000 | -6,800,000 | -10,900,000 | -8,500,000 | 0 | 0 | ||||
cash flows from financing activities: | ||||||||||||||||||||||||
borrowings from abl revolving credit facility and short-term borrowings | 80,000,000 | 190,000,000 | 300,000 | 64,900,000 | 59,500,000 | 100,200,000 | 212,400,000 | 130,800,000 | 371,800,000 | 75,800,000 | ||||||||||||||
repayments of abl revolving credit facility and short-term borrowings | -80,000,000 | -190,000,000 | -300,000 | -64,900,000 | -284,500,000 | -110,200,000 | -274,300,000 | -26,800,000 | -194,700,000 | -60,000,000 | ||||||||||||||
repayment of long-term debt | -5,300,000 | -5,300,000 | -5,300,000 | -5,400,000 | -5,500,000 | -10,900,000 | -5,500,000 | 0 | -5,400,000 | -5,500,000 | ||||||||||||||
dividend payment | -9,400,000 | -9,300,000 | ||||||||||||||||||||||
repurchase of common stock | 0 | -599,900,000 | ||||||||||||||||||||||
exercise of employee stock options | 9,200,000 | 14,400,000 | 4,500,000 | 12,900,000 | 7,800,000 | 2,200,000 | 1,800,000 | 200,000 | 100,000 | 1,000,000 | 1,500,000 | 500,000 | 1,200,000 | 900,000 | ||||||||||
employee taxes paid from shares withheld | -15,000,000 | -3,000,000 | -500,000 | -300,000 | -2,400,000 | -100,000 | 0 | 0 | -100,000 | -200,000 | ||||||||||||||
net cash from financing activities | -20,500,000 | -603,100,000 | -10,800,000 | 7,200,000 | -225,100,000 | -18,800,000 | -144,500,000 | 91,200,000 | 155,000,000 | -1,500,000 | 828,400,000 | -5,200,000 | -11,200,000 | 102,900,000 | 28,400,000 | -181,200,000 | 14,200,000 | 279,300,000 | 0 | -239,163 | ||||
effect of exchange rate changes on cash and cash equivalents | -5,700,000 | -6,000,000 | 6,200,000 | -3,700,000 | -2,800,000 | 1,800,000 | 5,700,000 | -7,400,000 | -8,800,000 | 1,300,000 | 700,000 | -3,500,000 | 1,400,000 | -3,100,000 | 6,900,000 | 4,300,000 | 200,000 | -6,400,000 | ||||||
increase in cash, cash equivalents and restricted cash | 307,200,000 | -508,100,000 | 283,600,000 | 224,800,000 | -600,000 | 7,600,000 | 4,500,000 | 63,400,000 | -91,200,000 | -150,600,000 | -304,500,000 | 34,800,000 | 31,600,000 | 142,600,000 | 210,300,000 | -47,600,000 | 76,500,000 | 69,700,000 | ||||||
beginning cash, cash equivalents and restricted cash | 0 | 788,600,000 | 0 | 0 | 0 | 273,200,000 | 0 | 0 | 0 | 447,100,000 | 0 | 0 | 0 | 542,600,000 | 0 | 0 | 0 | 233,700,000 | ||||||
ending cash, cash equivalents and restricted cash | 307,200,000 | 280,500,000 | 283,600,000 | 224,800,000 | -600,000 | 280,800,000 | 4,500,000 | 63,400,000 | -91,200,000 | 296,500,000 | -304,500,000 | 34,800,000 | 31,600,000 | 685,200,000 | 210,300,000 | -47,600,000 | 76,500,000 | 303,400,000 | ||||||
accounts receivable | -125,000,000 | 9,900,000 | -135,800,000 | -7,800,000 | -32,700,000 | -96,200,000 | -118,800,000 | -87,200,000 | -165,000,000 | -4,800,000 | -49,600,000 | -39,400,000 | -75,500,000 | 47,100,000 | -38,300,000 | -103,700,000 | ||||||||
inventories | -117,600,000 | -106,500,000 | 47,500,000 | -5,000,000 | -17,000,000 | -79,500,000 | -9,100,000 | -15,200,000 | -26,700,000 | -160,400,000 | 22,000,000 | -40,400,000 | -38,900,000 | -68,400,000 | 26,000,000 | 2,400,000 | -22,400,000 | -44,500,000 | ||||||
other current assets | 800,000 | -31,700,000 | 21,100,000 | 2,500,000 | 4,900,000 | -24,600,000 | 5,800,000 | 4,500,000 | -14,500,000 | -300,000 | 10,500,000 | -2,800,000 | -5,300,000 | -200,000 | 9,200,000 | -2,600,000 | 1,400,000 | |||||||
accounts payable | 120,500,000 | 9,800,000 | 27,200,000 | -8,300,000 | 25,700,000 | -62,300,000 | 90,600,000 | 21,600,000 | -12,400,000 | 33,000,000 | 42,000,000 | 12,200,000 | 30,200,000 | 20,700,000 | 57,400,000 | 41,900,000 | 22,300,000 | -43,400,000 | ||||||
deferred revenue | 154,700,000 | 100,000,000 | 89,600,000 | 23,300,000 | 17,100,000 | 144,200,000 | ||||||||||||||||||
accrued expenses and other liabilities | 60,100,000 | -68,500,000 | 46,000,000 | 18,000,000 | 44,000,000 | -16,500,000 | 61,300,000 | -1,100,000 | -45,100,000 | 30,500,000 | 6,200,000 | 21,700,000 | 25,500,000 | -41,500,000 | 16,100,000 | 113,200,000 | 4,300,000 | -120,300,000 | ||||||
income taxes | 2,600,000 | -12,700,000 | 38,500,000 | -23,600,000 | 11,800,000 | 18,500,000 | -600,000 | 5,900,000 | -17,000,000 | 100,000 | 6,900,000 | 1,500,000 | -20,000,000 | 2,800,000 | -19,700,000 | 3,500,000 | 5,200,000 | 4,200,000 | ||||||
total changes in operating working capital | 96,100,000 | -99,700,000 | 84,500,000 | 17,700,000 | 51,400,000 | -86,900,000 | -1,200,000 | -70,200,000 | -261,700,000 | -116,100,000 | 27,200,000 | -33,900,000 | -81,500,000 | -44,600,000 | 41,300,000 | 66,500,000 | -34,200,000 | -134,400,000 | ||||||
gain on tax receivable agreement | ||||||||||||||||||||||||
asset impairments | ||||||||||||||||||||||||
payment of contingent consideration | 0 | 0 | 0 | -8,700,000 | ||||||||||||||||||||
gain on sale of property, plant and equipment | ||||||||||||||||||||||||
changes in tax receivable agreement | 4,400,000 | 1,700,000 | -200,000 | 1,800,000 | ||||||||||||||||||||
acquisition of business | ||||||||||||||||||||||||
proceeds from sale of business | ||||||||||||||||||||||||
proceeds from the issuance of long-term debt | ||||||||||||||||||||||||
payment of debt issuance costs | 0 | |||||||||||||||||||||||
payment of tax receivable agreement | -75,000,000 | -12,500,000 | ||||||||||||||||||||||
proceeds from the exercise of warrants | 0 | 0 | 0 | 107,500,000 | ||||||||||||||||||||
supplemental disclosures | ||||||||||||||||||||||||
cash paid during the year for interest | ||||||||||||||||||||||||
cash paid during the year for income tax | ||||||||||||||||||||||||
property and equipment acquired during the year for capital lease obligations | ||||||||||||||||||||||||
noncash supplemental disclosure | ||||||||||||||||||||||||
seller provided financing for the disposition of property, plant and equipment | ||||||||||||||||||||||||
acquisition of business, net of cash acquired | 0 | 0 | ||||||||||||||||||||||
debt issuance costs | ||||||||||||||||||||||||
loss on extinguishment of debt | 0 | 0 | 0 | 400,000 | 0 | 0 | 0 | 174,000,000 | ||||||||||||||||
payment of redemption premiums | 0 | 0 | 0 | -75,000,000 | ||||||||||||||||||||
proceeds from reverse recapitalization | 0 | 0 | 5,500,000 | 1,827,000,000 | ||||||||||||||||||||
payment to vertiv stockholder | 0 | 0 | 0 | -341,600,000 | ||||||||||||||||||||
other financing | 100,000 | |||||||||||||||||||||||
asset impairment | ||||||||||||||||||||||||
stock based compensation | 6,600,000 | 5,700,000 | 6,200,000 | 5,600,000 | ||||||||||||||||||||
borrowings from abl revolving credit facility | 0 | 0 | 0 | 324,200,000 | ||||||||||||||||||||
repayments of abl revolving credit facility | -100,000,000 | -171,400,000 | -6,000,000 | -193,100,000 | ||||||||||||||||||||
proceeds from short-term borrowings | 0 | 1,800,000 | ||||||||||||||||||||||
repayment of short-term borrowings | -19,400,000 | |||||||||||||||||||||||
borrowing on term loan, net of discount | 0 | 0 | 0 | 2,189,000,000 | ||||||||||||||||||||
repayment on term loan | -5,500,000 | -5,400,000 | -5,500,000 | -5,500,000 | -5,500,000 | |||||||||||||||||||
repayment on prior term loan | 0 | 0 | 0 | -2,070,000,000 | ||||||||||||||||||||
repayment of prior notes | 0 | 0 | 0 | -1,370,000,000 | ||||||||||||||||||||
capitalized software write-off | ||||||||||||||||||||||||
gain on sale of business | ||||||||||||||||||||||||
proceeds from the issuance of 10.00% notes | ||||||||||||||||||||||||
payment of debt issuance cost | 0 | -11,200,000 | ||||||||||||||||||||||
accounts receivables | 68,200,000 | |||||||||||||||||||||||
change in operating assets and liabilities: | ||||||||||||||||||||||||
increase in dividend receivable | 174,890 | 173,884 | 75,707 | -64,254 | -458,769 | |||||||||||||||||||
(increase) in prepaid expenses | ||||||||||||||||||||||||
decrease in receivable from gs dc sponsor i llc | 0 | |||||||||||||||||||||||
increase in accounts payable | 4,828,934 | 722,807 | -260,294 | 127,569 | 443,297 | 74,889 | ||||||||||||||||||
increase in accrued tax payable | -214 | 0 | -810,713 | 716,488 | -617,196 | 607,423 | ||||||||||||||||||
net cash from /(used in) operating activities | ||||||||||||||||||||||||
proceeds from sponsor commitment | 1,300,000 | 0 | ||||||||||||||||||||||
proceeds from sale of units in public offering | 0 | 0 | ||||||||||||||||||||||
proceeds from sale of private placement warrants | 0 | 0 | ||||||||||||||||||||||
payment of underwriting discounts | 0 | 0 | ||||||||||||||||||||||
payment of offering costs | 0 | -239,163 | ||||||||||||||||||||||
proceeds from gs dc sponsor i llc promissory note | 0 | 0 | ||||||||||||||||||||||
repayment of gs dc sponsor i llc promissory note | 0 | 0 | ||||||||||||||||||||||
increase in cash and restricted cash | ||||||||||||||||||||||||
cash and restricted cash and cash equivalents at beginning of year | ||||||||||||||||||||||||
cash and restricted cash and cash equivalents at end of year | ||||||||||||||||||||||||
49 | ||||||||||||||||||||||||
increase in prepaid expenses | ||||||||||||||||||||||||
decrease in deferred offering costs | 0 | |||||||||||||||||||||||
net cash from / (used in) operating activities | 2,957,563 | |||||||||||||||||||||||
proceeds from sale of class a common stock to public | ||||||||||||||||||||||||
net cash provided by/ (used in) financing activities | 0 | |||||||||||||||||||||||
increase / (decrease) in cash and restricted cash | 2,957,563 | |||||||||||||||||||||||
cash and restricted cash and cash equivalents, at beginning of period | 0 | |||||||||||||||||||||||
cash and restricted cash and cash equivalents, at end of period | 2,957,563 | |||||||||||||||||||||||
item 2. | ||||||||||||||||||||||||
decrease in prepaid expenses | 46,340 | 4,378 | ||||||||||||||||||||||
increase in deferred tax receivable | ||||||||||||||||||||||||
increase / (decrease) in cash and restricted cash and cash equivalents | 3,478,760 | |||||||||||||||||||||||
cash and restricted cash and cash equivalents at beginning of period | 695,718,681 | |||||||||||||||||||||||
cash and restricted cash and cash equivalents at end of period | 699,197,441 | |||||||||||||||||||||||
dividend earned on investments held in trust account | ||||||||||||||||||||||||
(increase) in dividend receivable | ||||||||||||||||||||||||
increase in receivable from gs dc sponsor i llc | ||||||||||||||||||||||||
professional fees paid by gs sponsor llc on behalf of the company | ||||||||||||||||||||||||
proceeds deposited into trust account | 0 | 0 | ||||||||||||||||||||||
proceeds from sale of class b common stock to gs sponsor llc | ||||||||||||||||||||||||
increase in cash | -149,379 | -826,230 | ||||||||||||||||||||||
cash at beginning of year | ||||||||||||||||||||||||
cash at end of year | ||||||||||||||||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||||||||||||
cash paid out of trust account during the year for income taxes | ||||||||||||||||||||||||
supplemental disclosure of non-cash financing activities: | ||||||||||||||||||||||||
accrued offering costs | 0 | -154,163 | ||||||||||||||||||||||
deferred underwriting compensation | 0 | 0 | ||||||||||||||||||||||
2018 | ||||||||||||||||||||||||
general and administrative expenses | ||||||||||||||||||||||||
basic and diluted earning (loss) available to class a common stock | ||||||||||||||||||||||||
basic and diluted earning (loss) available to class b common stock | ||||||||||||||||||||||||
2017 | ||||||||||||||||||||||||
interest earned on investments held in trust account | ||||||||||||||||||||||||
cash at beginning of period | ||||||||||||||||||||||||
cash at end of period | -826,230 | |||||||||||||||||||||||
supplemental disclosure of non-cash financing activities | ||||||||||||||||||||||||
no. | ||||||||||||||||||||||||
31.1* | ||||||||||||||||||||||||
32.1** | ||||||||||||||||||||||||
101.ins* | ||||||||||||||||||||||||
101.sch* | ||||||||||||||||||||||||
101.cal* | ||||||||||||||||||||||||
101.def* | ||||||||||||||||||||||||
101.lab* | ||||||||||||||||||||||||
101.pre* | ||||||||||||||||||||||||
3.1 | ||||||||||||||||||||||||
4.4 | ||||||||||||||||||||||||
10.1 | ||||||||||||||||||||||||
10.2 | ||||||||||||||||||||||||
10.3 | ||||||||||||||||||||||||
10.4 | ||||||||||||||||||||||||
10.5 | ||||||||||||||||||||||||
10.6 | ||||||||||||||||||||||||
10.7 | ||||||||||||||||||||||||
10.8 | ||||||||||||||||||||||||
10.9 | ||||||||||||||||||||||||
10.10 |
We provide you with 20 years of cash flow statements for Vertiv stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Vertiv stock. Explore the full financial landscape of Vertiv stock with our expertly curated income statements.
The information provided in this report about Vertiv stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.